N@N

SeraCare Life Sciences to Ring NASDAQ Opening Bell on December 22, 2008

^{Published on 2008-12-19 05:48:31 - Market Wire}
 

MILFORD, Ma.--([ BUSINESS WIRE ])--SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that on December 22, 2008, the Company will ring The NASDAQ Stock Market^® Opening Bell at 9:30 A.M. eastern time to commemorate the relisting of the Company on the NASDAQ Capital Market as of June 23, 2008. SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics.

"Obtaining listing on NASDAQ was a major accomplishment for SeraCare and a fundamental step in rebuilding the organization and positioning it for future growth," said Susan Vogt, President and Chief Executive Officer. "Since our listing in June, we have continued to make substantial progress, introducing multiple new products and services and implementing several industry-leading quality initiatives. As we look to the New Year, we would like to take this opportunity to thank our employees, our customers and our shareholders for their continued support."

A live video feed of the NASDAQ Opening Bell will be available at:

[ http://www.nasdaq.com/about/marketsitetowervideo.asx ]

About SeraCare Life Sciences, Inc.

SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly-regulated life sciences industry.

Forward-Looking Statements

This press release contains disclosures that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about SeraCare Life Sciences, Inc. ("SeraCare" or the "Company"). All statements regarding our expected future financial position, results of operations, cash flows, dividends, financing plans, business strategy, budget, projected costs or cost savings, capital expenditures, competitive positions, growth opportunities for existing products or products under development, plans and objectives of management for future operations and markets for stock are forward-looking statements. In addition, forward-looking statements include statements in which we use words such as "expect," "believe," "anticipate," "intend," or similar expressions. Although we believe the expectations reflected in such forward-looking statements are based on reasonable assumptions, we cannot assure you that these expectations will prove to have been correct, and actual results may differ materially from those reflected in the forward-looking statements. Factors that could cause our actual results to differ from the expectations reflected in the forward-looking statements in this press release include, but are not limited to, failure to maintain proper inventory levels, availability of financing, covenant limitations in our existing credit facility, reductions or terminations of government or other contracts, interruption in our supply of products or raw materials, actions of SeraCare's competitors and changes in the regulatory environment. Many of these factors are beyond our ability to control or predict.